PetVivo Holdings, Inc. (PETV)

Market Cap	16.96M
Revenue (ttm)	968.63K
Net Income (ttm)	-8.62M
Shares Out	21.20M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	34,167
Open	0.770
Previous Close	0.821
Day's Range	0.770 - 0.821
52-Week Range	0.290 - 1.335
Beta	2.38
RSI	55.06
Earnings Date	Feb 7, 2025

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In 2023, PetVivo Holdings's revenue was $968,706, an increase of 5.62% compared to the previous year's $917,162. Losses were -$10.96 million, 25.7% more than in 2022.